Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
National Institute for Health and Care Excellence
23h
New Alzheimer’s treatment donanemab does not currently demonstrate value for the NHS says NICE
Donanemab (also called Kisunla and made by Eli Lilly) has been licensed today by the MHRA for treatment of mild cognitive impairment or mild dementia due to Alzheimer’s disease in some adults. It is a ...
National Institute for Health and Care Excellence
2d
Breast cancer
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Workers reject new contract
Settles civil lawsuit
NK troops in RU confirmed
Suffers 'debilitating' stroke
Joins Republican Party
DOJ warns Musk's PAC?
Courthouse attack charges
Court orders new sentence
Closing argument speech plan
$3.9B storm relief proposal
'Tarzan' star Ron Ely dies
Timberlake postpones shows
Settles hazardous waste suit
Yelp disables reviews
FDA recalls antidepressant
Biden says lock up Trump
DNC office shootings arrest
Existing home sales fall
Israel strikes Lebanese city
Kentucky lawmaker dies
Hashem Safieddine killed
First father-son duo in NBA
Apple, Goldman Sachs fined
G7 Ukraine loan advances
Lake Erie toxic algae study
US fines American Airlines
Dodgers legend dies
MO court upholds release
To close 150 locations
DOJ alleges racial bias
Feedback